PHOENIX, Nov. 11, 2016 /PRNewswire/ -- (OTC Pink: LBTD) Lotus Biotechnology Development, Corp. is pleased to announce that the Company prepares to release its premium organic Cannabinoid derived products, enabling the Lotus Biotechnologies to aggressively compete in the CBD sector of the ever-strengthening legal US market. These movements now position the Company to bring exclusive premium organic CBD products to a greatly widened marketplace, bolstering the Company's already remarkable growth potential. The Company has formulated a line of top quality blends by enhancing its premium organic products with the integration of pharmaceutical marijuana. Management is strategizing the branding, marketing, and sales, finalizing product development, and preparing to conclude manufacturing on the Company's first line of exclusive organic CBD products to hit the retail market. "We are excited to be at the threshold of a new age in the cannabis industry, and having built our operation to the point at which we currently stand, we are delighted to be so well positioned as lucrative new venues open and demands rise," stated Michael Palethorpe, Chief Executive Officer and President, Lotus Biotechnologies. As a growing number of states have recently legalized medical and recreational distribution, the demand for quality CBD products is expected to experience a sharp incline. On November the 8th, the industry achieved a notable victory expanding the legal marketplace to include Florida, Arkansas, Montana, and North Dakota on a medical level, while Massachusetts, Nevada, and California legalized recreational marijuana. In a recent article featured in the Washington Post it was stated: "This is the most momentous Election Day in history for the movement to end marijuana prohibition," Rob Kampia of the Marijuana Policy Project, a group that supported a number of the legalization initiatives, said in a statement. "The end of prohibition is near…" Mr. Palethorpe concluded: "As we continue to fortify our top quality line of organic CBD enhanced merchandise, we maintain a focus driven toward the continual strengthening of our position. There is so much room for profitability in this continually growing market, and we intend to capitalize on the amazing opportunity to lead with premium organics in the emergent CBD markets. As details on these products are finalized and prepared for release, we will be prompt to update the investment community."